Q32 Bio Inc. (QTTB) income statement
QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$8.48−0.05 (-0.59%)
Close on Nov 19, 2026Market cap $252.45MP/E –Yield –
Q32 Bio Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- –
- Operating margin
- 39.9%
- Net margin
- 62.9%
- Return on equity, FY2025
- 125.1%
Financial strength
- Current ratio
- 20.30
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 1967.6%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.38
- Dividend yield
- –
See a number that looks wrong?